Advertisement
U.S. markets closed

Alector, Inc. (ALEC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
3.9400+0.1800 (+4.79%)
At close: 04:00PM EST
4.0100 +0.07 (+1.78%)
After hours: 06:25PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close3.7600
Open3.8100
Bid3.9100 x 200
Ask3.9800 x 200
Day's Range3.7500 - 4.1100
52 Week Range3.4900 - 8.9000
Volume715,703
Avg. Volume592,968
Market Cap385.854M
Beta (5Y Monthly)0.66
PE Ratio (TTM)N/A
EPS (TTM)-1.7100
Earnings DateNov 06, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.50
  • GlobeNewswire

    Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital

    SOUTH SAN FRANCISCO, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that the Company has entered into a debt financing agreement with Hercules Capital, Inc. (NYSE: HTGC) for up to $50 million. “Alector is in a strong cash position with more than $457 million in cash and investments. This credit facility further enhances our financial strength and provides the Company with increased strate

  • Zacks

    Alector (ALEC) Reports Q3 Loss, Misses Revenue Estimates

    Alector (ALEC) delivered earnings and revenue surprises of 18.87% and 6.06%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?